- Home
- GPK vs LEGN Comparison
GPK vs LEGN Comparison
Compare GPK & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPK
- LEGN
- Stock Information
- Founded
- GPK 2007
- LEGN 2014
- Country
- GPK United States
- LEGN United States
- Employees
- GPK N/A
- LEGN N/A
- Industry
- GPK Containers/Packaging
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- GPK Consumer Discretionary
- LEGN Health Care
- Exchange
- GPK Nasdaq
- LEGN Nasdaq
- Market Cap
- GPK 7.4B
- LEGN 7.0B
- IPO Year
- GPK 1992
- LEGN 2020
- Fundamental
- Price
- GPK $23.26
- LEGN $31.08
- Analyst Decision
- GPK Buy
- LEGN Strong Buy
- Analyst Count
- GPK 7
- LEGN 13
- Target Price
- GPK $29.17
- LEGN $79.42
- AVG Volume (30 Days)
- GPK 3.5M
- LEGN 1.6M
- Earning Date
- GPK 05-01-2025
- LEGN 05-13-2025
- Dividend Yield
- GPK 1.89%
- LEGN N/A
- EPS Growth
- GPK N/A
- LEGN N/A
- EPS
- GPK 2.05
- LEGN N/A
- Revenue
- GPK $8,668,000,000.00
- LEGN $728,303,000.00
- Revenue This Year
- GPK N/A
- LEGN $65.96
- Revenue Next Year
- GPK $2.60
- LEGN $52.55
- P/E Ratio
- GPK $11.36
- LEGN N/A
- Revenue Growth
- GPK N/A
- LEGN 112.46
- 52 Week Low
- GPK $20.86
- LEGN $29.27
- 52 Week High
- GPK $30.70
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- GPK 45.14
- LEGN 39.41
- Support Level
- GPK $21.12
- LEGN $30.25
- Resistance Level
- GPK $22.49
- LEGN $33.30
- Average True Range (ATR)
- GPK 0.65
- LEGN 1.53
- MACD
- GPK -0.02
- LEGN -0.18
- Stochastic Oscillator
- GPK 48.48
- LEGN 26.21
About GPK Graphic Packaging Holding Company
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.